- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 276.95M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 276.74M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 220.58M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $8.25M |
| Capex | Q1 2026 · Mar 31, 2026 | $7.3K |
| Capex | Q1 2026 · Mar 31, 2025 | $3.2K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $17.89M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$9.74M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $451.2K |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $442.6K |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $958.14M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $207.37M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $305.05M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $249.07M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $134.56M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $146.13M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.25B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.65B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $980.23M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $980.1M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $983.45M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $982.82M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.05B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.2B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.24B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.63B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.47 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.14 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.47 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.14 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $37.94M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $25.18M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $8.4M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $12.56M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$293.49M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$39.54M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.5M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $336.7K |
| Revenue | Q1 2026 · Mar 31, 2026 | $871.2K |
| Revenue | Q1 2026 · Mar 31, 2025 | $821.2K |